[PHAS] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
09-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -49.82%
YoY- -65.64%
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 764 241 703 653 257 411 0 -
PBT -11,331 -11,391 -9,232 -7,293 -4,868 -7,901 -6,674 42.17%
Tax 314 465 469 317 2,975 -2,012 -1,120 -
NP -11,331 -11,391 -9,232 -7,293 -4,868 -7,901 -6,674 42.17%
Tax Rate - - - - - - - -
Total Cost 12,095 11,632 9,935 7,946 5,125 8,312 6,674 48.48%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -1,483.12 -4,726.56 -1,313.23 -1,116.85 -1,894.16 -1,922.38 0.00 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -0.39 -0.40 -0.33 -0.30 -0.26 -0.40 -0.34 9.55%
EPS Diluted -0.39 -0.40 -0.33 -0.30 -0.26 -0.40 -0.34 9.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.